Cancer BiologybioRxivPreprint
Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology
Annika Schneider, Julia Wortmann, Cecilia Bang Jensen…·Bernhard Küster
This study uses pan-cancer phosphoproteomics to identify therapeutic targets and improve precision oncology by analyzing 1,998 tumor samples and developing new scores for kinase activity and immune response.
DOI 10.64898/2026.07.08.737171